OncoSec Medical Incorporated
ONCS
ONCS was delisted on the 23rd of June, 2023.
33 hedge funds and large institutions have $2.64M invested in OncoSec Medical Incorporated in 2018 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 10 increasing their positions, 8 reducing their positions, and 7 closing their positions.
25% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 8
14% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 7
3% more funds holding
Funds holding: 32 → 33 (+1)
75% less capital invested
Capital invested by funds: $10.4M → $2.64M (-$7.73M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$735K |
| 2 |
BlackRock
New York
|
+$275K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$187K |
| 4 |
Bank of New York Mellon
New York
|
+$95K |
| 5 |
ARTA
A.R.T. Advisors
New York
|
+$81.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NC
Nexthera Capital
New York
|
-$1.94M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.56M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.17M |
| 4 |
ACA
Avoro Capital Advisors
New York
|
-$700K |
| 5 |
DS
DRW Securities
Chicago,
Illinois
|
-$210K |
ONCS Hedge Fund Activity: Q4 2018 in Review
33 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in OncoSec Medical Incorporated (ONCS) for Q4 2018, worth a combined $2.64M — down 75% from $10.4M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new ONCS positions and 7 closed out — a net gain of 1 holder — while 10 added to existing stakes and 8 trimmed.
The largest buyer was Anson Funds Management, opening a new position worth an estimated $735K. The largest seller was Nexthera Capital, exiting entirely with an estimated $1.94M sold.
- 33 institutional investors held OncoSec Medical Incorporated (ONCS) as of Q4 2018, up from 32 in Q3 2018.
- Funds reported $2.64M of OncoSec Medical Incorporated stock for Q4 2018, down 75% quarter-over-quarter.
- 8 funds opened new OncoSec Medical Incorporated positions in Q4 2018 and 7 closed out, a net change of +1 holder.
- The largest OncoSec Medical Incorporated buyer in Q4 2018 was Anson Funds Management, an estimated $735K added.
- The largest OncoSec Medical Incorporated seller in Q4 2018 was Nexthera Capital, an estimated $1.94M sold.
Based on aggregated 13F filings for Q4 2018.